Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Biologics Manufacturing Global Market Report 2025
Download Free Sample Buy Now
Global Biologics Manufacturing Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Biologics Manufacturing Global Market Report 2025

By Mode of Manufacturing (Contract Manufacturing, In-House Manufacturing), By Modality (Monoclonal Antibodies (mAbs), Biosimilar And Recombinant Proteins, Vaccines (recombinant/mRNA/Viral), Cell And Gene Therapies, Ribonucleic Acid-Based Therapeutics), By Disease Indication (Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Disorders, Other Disease Indications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biologics Manufacturing Market Overview

• Biologics Manufacturing market size has reached to $34.82 billion in 2024

• Expected to grow to $88.28 billion in 2029 at a compound annual growth rate (CAGR) of 20.4%

• Growth Driver: Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Therapies

• Market Trend: Advanced Biologics CDMO Platforms Enable Faster Development Timelines

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biologics Manufacturing Market?

Biologics manufacturing is the complex process of producing medicines derived from living organisms or their components. It involves cultivating genetically engineered cells or microorganisms in bioreactors to generate therapeutic proteins or other biological products, followed by purification techniques like filtration and chromatography to ensure safety and quality. This process enables the development of safe, effective, and high-quality biologic drugs, supporting personalized medicine and improving patient outcomes.

The main modes of manufacturing in biologics manufacturing are contract manufacturing and in-house manufacturing. Contract manufacturing refers to a production approach in which a company outsources the manufacturing of its biologic products to a specialized third-party organization. The different modalities include monoclonal antibodies (mabs), biosimilar and recombinant proteins, vaccines, cell and gene therapies, and ribonucleic acid-based therapeutics, and are indicated for oncology, autoimmune disorders, infectious diseases, neurological disorders, and other disease indications.

Biologics Manufacturing Market Size and growth rate 2025 to 2029: Graph

What Is The Biologics Manufacturing Market Size 2025 And Growth Rate?

The biologics manufacturing market size has grown exponentially in recent years. It will grow from $34.82 billion in 2024 to $42.04 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing demand for therapeutic proteins, rising prevalence of chronic diseases, growing use of monoclonal antibodies, increasing government support for biologics development, and rising adoption of contract manufacturing organizations.

What Is The Biologics Manufacturing Market Growth Forecast?

The biologics manufacturing market size is expected to see exponential growth in the next few years. It will grow to $88.28 billion in 2029 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to growing demand for personalized medicine, increasing investments in cell and gene therapies, rising adoption of advanced bioprocessing technologies, increasing focus on sustainable manufacturing processes, and growing pipeline of biologic drug candidates. Major trends in the forecast period include a shift toward continuous bioprocessing, adoption of single-use technologies, expansion of modular biomanufacturing facilities, integration of AI and automation in production, and focus on sustainable and green manufacturing practices.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Biologics Manufacturing Market Segmented?

1) By Mode of Manufacturing: Contract Manufacturing, In-House Manufacturing

2) By Modality: Monoclonal Antibodies (mAbs), Biosimilar And Recombinant Proteins, Vaccines (recombinant/mRNA/Viral), Cell And Gene Therapies, Ribonucleic Acid-Based Therapeutics

3) By Disease Indication: Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Disorders, Other Disease Indications

Subsegments:

1) By Contract Manufacturing: Mammalian Cell-Based Production, Microbial Fermentation Production, Cell-Free Protein Synthesis, Hybrid Manufacturing Systems

2) By In-House Manufacturing: Mammalian Cell Culture Production, Microbial Expression Systems, Continuous Bioprocessing, Single-Use Technology Production

What Is Driving The Biologics Manufacturing Market? Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Therapies

The rising prevalence of chronic diseases is expected to propel the growth of the biologics manufacturing market going forward. Chronic diseases are persistent health conditions that develop slowly and last for an extended period, often requiring continuous medical care. The growing prevalence of chronic diseases is partly due to inactive lifestyles, as prolonged sitting and minimal physical activity raise the risk of diseases such as heart conditions and diabetes. Biologics manufacturing enhances chronic disease management by producing targeted therapies, making them effective for conditions such as diabetes, cancer, and autoimmune disorders. It reduces disease burden by providing consistent, high-quality biologic medicines, improving patient outcomes and treatment efficiency. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the biologics manufacturing industry.

Who Are The Major Players In The Global Biologics Manufacturing Market?

Major companies operating in the biologics manufacturing market are Johnson & Johnson, F. Hoffmann La-Roche Ltd., Pfizer Inc, AbbVie Inc., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lonza Group Ltd., Intas Pharmaceuticals Ltd., Samsung Biologics Co. Ltd., Fareva SA, Celltrion Inc., Evotec SE

What Are The Key Trends Of The Global Biologics Manufacturing Market? Advanced Biologics CDMO Platforms Enable Faster Development Timelines

Major companies operating in the biologics manufacturing market are focusing on developing advanced solutions, such as integrated biologics contract development and manufacturing organization platforms, to enhance end-to-end biologics development, production efficiency, and supply chain integration across multiple therapeutic modalities. Integrated biologics contract development and manufacturing organization (CDMO) platform refers to a comprehensive framework that combines biologics development, production, and supply services within a single, unified system. For instance, in June 2023, Catalent Inc., a US-based contract development and manufacturing company, expanded its OneBio Suite for integrated development, manufacturing, and supply across biologic modalities. The enhanced OneBio Suite offers a fully integrated biologics Contract Development and Manufacturing Organization (CDMO) platform that supports antibodies, cell and gene therapies, and mRNA-based products. It provides end-to-end services from development to fill-finish and packaging through a single contract and harmonized project management, enabling faster development timelines, improved scalability, and seamless global supply integration.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Biologics Manufacturing Market? Terumo Strengthens End-To-End Biologics Capabilities With WuXi Deal

In September 2025, Terumo Corporation, a Japan-based medical technology company, acquired WuXi Biologics (Cayman) Inc. for an undisclosed amount. Through this acquisition, Terumo aims to expand its CDMO production capacity and global presence, enhancing its ability to provide integrated biologics manufacturing and fill-finish services for injectable therapies. WuXi Biologics (Cayman) Inc. is a China-based company offering end-to-end solutions for the discovery, development, and manufacturing of biologics.

What Is The Regional Outlook For The Global Biologics Manufacturing Market?

North America was the largest region in the biologics manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biologics Manufacturing Market?

The biologics manufacturing market consists of sales of therapeutic proteins, enzymes, recombinant DNA products, blood factors, and other biologic-based therapeutics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biologics Manufacturing Industry?

The biologics manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biologics manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biologics Manufacturing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $42.04 billion
Revenue Forecast In 2034 $88.28 billion
Growth Rate CAGR of 20.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Mode of Manufacturing, Modality, Disease Indication
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson, F. Hoffmann La-Roche Ltd., Pfizer Inc, AbbVie Inc., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lonza Group Ltd., Intas Pharmaceuticals Ltd., Samsung Biologics Co. Ltd., Fareva SA, Celltrion Inc., Evotec SE
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biologics Manufacturing Market Characteristics

3. Biologics Manufacturing Market Trends And Strategies

4. Biologics Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biologics Manufacturing Growth Analysis And Strategic Analysis Framework

5.1. Global Biologics Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biologics Manufacturing Market Growth Rate Analysis

5.4. Global Biologics Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biologics Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biologics Manufacturing Total Addressable Market (TAM)

6. Biologics Manufacturing Market Segmentation

6.1. Global Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Contract Manufacturing

In-House Manufacturing

6.2. Global Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies (mAbs)

Biosimilar And Recombinant Proteins

Vaccines

Cell And Gene Therapies

Ribonucleic Acid-Based Therapeutics

Others Modalitys

6.3. Global Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Autoimmune Disorders

Infectious Diseases

Neurological Disorders

Cardiovascular Disorders

Other Disease Indications

6.4. Global Biologics Manufacturing Market, Sub-Segmentation Of Contract Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mammalian Cell-Based Production

Microbial Fermentation Production

Cell-Free Protein Synthesis

Hybrid Manufacturing Systems

6.5. Global Biologics Manufacturing Market, Sub-Segmentation Of In-House Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mammalian Cell Culture Production

Microbial Expression Systems

Continuous Bioprocessing

Single-Use Technology Production

7. Biologics Manufacturing Market Regional And Country Analysis

7.1. Global Biologics Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biologics Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics Manufacturing Market

8.1. Asia-Pacific Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics Manufacturing Market

9.1. China Biologics Manufacturing Market Overview

9.2. China Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics Manufacturing Market

10.1. India Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics Manufacturing Market

11.1. Japan Biologics Manufacturing Market Overview

11.2. Japan Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics Manufacturing Market

12.1. Australia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics Manufacturing Market

13.1. Indonesia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics Manufacturing Market

14.1. South Korea Biologics Manufacturing Market Overview

14.2. South Korea Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics Manufacturing Market

15.1. Western Europe Biologics Manufacturing Market Overview

15.2. Western Europe Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics Manufacturing Market

16.1. UK Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics Manufacturing Market

17.1. Germany Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics Manufacturing Market

18.1. France Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics Manufacturing Market

19.1. Italy Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics Manufacturing Market

20.1. Spain Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics Manufacturing Market

21.1. Eastern Europe Biologics Manufacturing Market Overview

21.2. Eastern Europe Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics Manufacturing Market

22.1. Russia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics Manufacturing Market

23.1. North America Biologics Manufacturing Market Overview

23.2. North America Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics Manufacturing Market

24.1. USA Biologics Manufacturing Market Overview

24.2. USA Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics Manufacturing Market

25.1. Canada Biologics Manufacturing Market Overview

25.2. Canada Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics Manufacturing Market

26.1. South America Biologics Manufacturing Market Overview

26.2. South America Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics Manufacturing Market

27.1. Brazil Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics Manufacturing Market

28.1. Middle East Biologics Manufacturing Market Overview

28.2. Middle East Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics Manufacturing Market

29.1. Africa Biologics Manufacturing Market Overview

29.2. Africa Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics Manufacturing Market Competitive Landscape And Company Profiles

30.1. Biologics Manufacturing Market Competitive Landscape

30.2. Biologics Manufacturing Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann La-Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Biologics Manufacturing Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Bristol-Myers Squibb Company

31.3. Thermo Fisher Scientific Inc.

31.4. LG Life Sciences Ltd.

31.5. Novo Nordisk A/S

31.6. Amgen Inc.

31.7. FUJIFILM Holdings Corporation

31.8. Boehringer Ingelheim International GmbH

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Lonza Group Ltd.

31.11. Intas Pharmaceuticals Ltd.

31.12. Samsung Biologics Co. Ltd.

31.13. Fareva SA

31.14. Celltrion Inc.

31.15. Evotec SE

32. Global Biologics Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics Manufacturing Market

34. Recent Developments In The Biologics Manufacturing Market

35. Biologics Manufacturing Market High Potential Countries, Segments and Strategies

35.1 Biologics Manufacturing Market In 2029 - Countries Offering Most New Opportunities

35.2 Biologics Manufacturing Market In 2029 - Segments Offering Most New Opportunities

35.3 Biologics Manufacturing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biologics Manufacturing Market, Sub-Segmentation Of Contract Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biologics Manufacturing Market, Sub-Segmentation Of In-House Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biologics Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biologics Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Johnson & Johnson Financial Performance
  • Table 77: F. Hoffmann La-Roche Ltd. Financial Performance
  • Table 78: Pfizer Inc Financial Performance
  • Table 79: AbbVie Inc. Financial Performance
  • Table 80: Eli Lilly and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biologics Manufacturing Market, Sub-Segmentation Of Contract Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biologics Manufacturing Market, Sub-Segmentation Of In-House Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biologics Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biologics Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Johnson & Johnson Financial Performance
  • Figure 77: F. Hoffmann La-Roche Ltd. Financial Performance
  • Figure 78: Pfizer Inc Financial Performance
  • Figure 79: AbbVie Inc. Financial Performance
  • Figure 80: Eli Lilly and Company Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

Read More About Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Read More About $8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

Read More About Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Biologics Contract Development Global Market Report 2025 – By Source (Microbial, Mammalian, Others Sources), By Indication (Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Ind...

View Report

Biologics Outsourcing Global Market Report 2025 – By Product Type (Antibodies, Recombinant, Vaccines, Protein, Other Products), By Source (Human, Microbial, Other Source), By Application (Oncology, Cellular and Gene Ther...

View Report

Biologics Testing Global Market Report 2025 – By Product (Reagents And Kits, Instruments, Other Products), By Test Type (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And ...

View Report

Agricultural Biologics Global Market Report 2025 – By Type (Biopesticides, Biofertilizers, Biostimulants), By Source (Microbials, Macrobials, Biochemicals, Other Sources), By Mode of Application (Foliar Spray, Soil Treat...

View Report

Biopharmaceuticals Contract Manufacturing Global Market Report 2025 – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars), By Source (...

View Report

Veterinary Biologics Global Market Report 2025 – By Product (Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products), By Disease Type (Bluetongue, Foot And Mouth Disease, Brucellosis And T...

View Report

Digital Biomanufacturing Global Market Report 2025 – By Type (Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types), By Types of Biologic (s) Manufactured (Antibodies, Cell And G...

View Report

Biologics CDMO Global Market Report 2025 – By Cell Type (Mammalian, Non-Mammalian), By Product Type (Biologics, Biosimilars) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034...

View Report

Frequently Asked Questions

Biologics manufacturing is the complex process of producing medicines derived from living organisms or their components. It involves cultivating genetically engineered cells or microorganisms in bioreactors to generate therapeutic proteins or other biological products, followed by purification techniques like filtration and chromatography to ensure safety and quality. This process enables the development of safe, effective, and high-quality biologic drugs, supporting personalized medicine and improving patient outcomes. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Therapies. For further insights on this market, request a sample here

The biologics manufacturing market size has grown exponentially in recent years. It will grow from $34.82 billion in 2024 to $42.04 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing demand for therapeutic proteins, rising prevalence of chronic diseases, growing use of monoclonal antibodies, increasing government support for biologics development, and rising adoption of contract manufacturing organizations. The biologics manufacturing market size is expected to see exponential growth in the next few years. It will grow to $88.28 billion in 2029 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to growing demand for personalized medicine, increasing investments in cell and gene therapies, rising adoption of advanced bioprocessing technologies, increasing focus on sustainable manufacturing processes, and growing pipeline of biologic drug candidates. Major trends in the forecast period include a shift toward continuous bioprocessing, adoption of single-use technologies, expansion of modular biomanufacturing facilities, integration of AI and automation in production, and focus on sustainable and green manufacturing practices. For further insights on this market, request a sample here

The biologics manufacturing market covered in this report is segmented –
1) By Mode of Manufacturing: Contract Manufacturing, In-House Manufacturing
2) By Modality: Monoclonal Antibodies (mAbs), Biosimilar And Recombinant Proteins, Vaccines (recombinant/mRNA/Viral), Cell And Gene Therapies, Ribonucleic Acid-Based Therapeutics
3) By Disease Indication: Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Disorders, Other Disease Indications Subsegments:
1) By Contract Manufacturing: Mammalian Cell-Based Production, Microbial Fermentation Production, Cell-Free Protein Synthesis, Hybrid Manufacturing Systems
2) By In-House Manufacturing: Mammalian Cell Culture Production, Microbial Expression Systems, Continuous Bioprocessing, Single-Use Technology Production For further insights on this market, request a sample here

North America was the largest region in the biologics manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the biologics manufacturing market are Johnson & Johnson, F. Hoffmann La-Roche Ltd., Pfizer Inc, AbbVie Inc., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lonza Group Ltd., Intas Pharmaceuticals Ltd., Samsung Biologics Co. Ltd., Fareva SA, Celltrion Inc., Evotec SE . For further insights on this market, request a sample here.

Major trends in this market include Advanced Biologics CDMO Platforms Enable Faster Development Timelines. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Biologics Manufacturing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon